isoflurane has been researched along with Cancer of Pituitary in 1 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gopalakrishna, KN | 1 |
Dash, PK | 1 |
Chatterjee, N | 1 |
Easwer, HV | 1 |
Ganesamoorthi, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparative Low and High Dose of Dexmedethomidine Can Stabilize Hemodynamics and Blood Loss in Pituitary Tumor Removal by Transphenoid Approach[NCT03132259] | Phase 4 | 124 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | ||
Recovery Profiles After c Spine Surgery: With or Without Dexmedetomidine as an Anesthetic Adjuvant[NCT02819089] | 100 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | |||
Effect of Dexmedetomidine as Anesthetic Coadjuvant on Plasmatic Cortisol Response in Transsphenoidal Surgery for Pituitary Tumors[NCT02549768] | Phase 4 | 40 participants (Anticipated) | Interventional | 2015-09-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for isoflurane and Cancer of Pituitary
Article | Year |
---|---|
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |
Dexmedetomidine as an Anesthetic Adjuvant in Patients Undergoing Transsphenoidal Resection of Pituitary Tumor.
Topics: Adjuvants, Anesthesia; Adult; Analysis of Variance; Anesthesia Recovery Period; Anesthetics, Inhalat | 2015 |